NEO

NEOGENOMICS INC

NEO·64049M209·US·Common Stock·Healthcare - Diagnostics & Research-13D/G

NEO (NEOGENOMICS INC) is held by 133 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($148.1M), VANGUARD PORTFOLIO MANAGEMENT LLC ($56.6M), FIRST TRUST ADVISORS LP ($45.7M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 77 funds bought NEO.

133
Holders
(14 Elite)
$699.3M
Total Value
58% (133)
Consensus
77 buying - 56 selling
13F: Insider & Congress:
NEO

Smart Money Verdict

View all
Held by 133 funds
14 elite

Who's Trading

InsiderADAunan Greg DSell $321KAug 4, 2026
ActivistFTFirst Trust Portfolios L.P.7.8%Jul 30, 2026
ActivistBlackRock, Inc.BlackRock, Inc.15.6%Jul 30, 2026
InsiderTATETRAULT LYNN A.Sell $59KJun 15, 2026
InsiderTATETRAULT LYNN A.Sell $60KJun 9, 2026
ActivistGLGreenhouse Funds LLLP7.1%May 15, 2026
ActivistMillennium Management LLCMillennium Management LLC1.7%May 13, 2026
ActivistMPMathew P. Arens10.8%May 7, 2026
InsiderSWStone WarrenExercise 6K shMay 2, 2026
CongressGilbert CisnerosGilbert CisnerosBuy $1,001 - $15,000May 7, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
20M(+2.5%)$148.1M0.0%-0.77%
31
New
7.6M$56.6M0.0%+73.69%
41
New
6.2M$45.7M0.0%+73.69%
40
New
5.7M$42M0.0%+73.69%
40
Increased
5.1M(+2.8%)$38M0.0%+3.81%
30
Decreased
4.2M(-21.4%)$30.9M0.0%+77.22%
0
Decreased
3.6M(-11.2%)$25.7M0.0%-10.68%
0
Decreased
3.5M(-12.3%)$25.6M0.0%+35.49%
0
Increased
3.2M(+1.7%)$24M0.0%-14.44%
29
Increased
3.1M(+126.6%)$22.7M0.0%+36.37%
46
Increased
2.7M(+9.2%)$19.8M0.0%+11.42%
31
Decreased
2.2M(-57.3%)$16.5M0.0%+71.73%
0
Increased
2.2M(+1.7%)$16M0.0%+48.79%
29
Increased
2M(+12.7%)$15M0.0%+56.90%
32
Increased
1.9M(+19.3%)$14.4M0.0%+40.48%
33
Decreased
1.7M(-30.3%)$12.8M0.1%+35.49%
0
Increased
1.6M(+11.1%)$11.7M0.0%-4.91%
31
Decreased
1.3M(-8.1%)$9.6M0.0%+11.32%
0
Decreased
1.2M(-2.4%)$8.8M0.0%-9.00%
0
Decreased
1M(-30.0%)$7.4M0.0%+8.32%
0

Showing 1-20 of 145

1 / 8
NEONEONEOGENOMICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used